Detalles de la búsqueda
1.
Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer.
Ann Oncol
; 28(10): 2436-2442, 2017 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28961836
2.
FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer.
Br J Cancer
; 115(10): 1223-1233, 2016 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27685445
3.
Combined robotic approach and enhanced recovery after surgery pathway for optimization of costs in patients undergoing proctectomy.
BJS Open
; 4(3): 516-523, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32352227
4.
Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy.
Oncogene
; 33(47): 5405-14, 2014 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24240689
Resultados
1 -
4
de 4
1
Próxima >
>>